Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19

[Image: see text] COVID-19 is a biphasic infectious disease with no approved vaccine or pharmacotherapy. The first drug that has shown promise in reducing COVID-19 mortality in severely-ill patients is dexamethasone, a cheap, well-known anti-inflammatory glucocorticoid, approved for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajjo, Rima, Sabbah, Dima A., Bardaweel, Sanaa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689662/
https://www.ncbi.nlm.nih.gov/pubmed/33251412
http://dx.doi.org/10.1021/acsomega.0c03597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689662/
https://www.ncbi.nlm.nih.gov/pubmed/33251412
http://dx.doi.org/10.1021/acsomega.0c03597

Ejemplares similares